Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance

Overview of attention for article published in OncoTargets and therapy, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

Grant US-11603367-B2

United States of America

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

Application WO-2022185260-A1

World Intellectual Property Organisation (WIPO)